Evidence map›Paper›PMID 19372458›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2009

Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.

Huan Wang, Weiyu Zhang, Rong Tang, Robert P Hebbel, M Anna Kowalska, Chunxiang Zhang, Jamey D Marth, Minoru Fukuda, Chuhong Zhu, Yuqing Huo

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Huan WangDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Weiyu Zhang
Rong Tang
Robert P Hebbel
M Anna Kowalska
Chunxiang Zhang
Jamey D Marth
Minoru Fukuda
Chuhong Zhu
Yuqing Huo
Children's Hospital of Philadelphia · USUniversity of Minnesota · USRutgers New Jersey Medical School

Funding

Structural Basis of Immune Recognition of Glycosylated AntigensU54GM062116 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI KANEHISA, MINORU · 2001 to 2010
$80.3M
The Interaction of TPO and Integrins in Hematopoiesis CellsP01HL078784 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GINSBERG, MARK HOWARD · 2005 to 2019
$28.3M
Siglec Modulation of Inflammation in Humans and MiceP01HL057345 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARTH, JAMEY · 1997 to 2012
$24.1M
GLYCOPROTEINS IN DIFFERENTIATION AND ONCOGENESISR01CA033000 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FUKUDA, MINORU · 1985 to 2009
$1.8M
Role of miR-145 in Vascular Smooth Muscle Cell BiologyRole ofR01HL095707 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ZHANG, CHUNXIANG · 2010 to 2013
$1.5M
MPO and NO signaling in neointima formationR01HL080133 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ZHANG, CHUNXIANG · 2006 to 2010
$1.5M
Leukocyte C2GIcNAcT-I in atherosclerosisR01HL080569 · NHLBI · UNIVERSITY OF MINNESOTA · PI HUO, YUQING · 2006 to 2009
$1.4M
Inhibition of leukocyte C2GlcNAcT--l reduces thrombosisR01HL078679 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HUO, YUQING · 2004 to 2007
$1.2M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA033000NHLBI NIH HHS HL080569NHLBI NIH HHS HL57345NHLBI NIH HHS HL78679,NHLBI NIH HHS HL78784NHLBI NIH HHS P01 HL057345NHLBI NIH HHS P01 HL078784NHLBI NIH HHS R01 HL078679NHLBI NIH HHS R01 HL080133NHLBI NIH HHS R01 HL080569NHLBI NIH HHS R01 HL095707NIGMS NIH HHS GM62116
6 · The paper itself

Abstract

objectiveCore2 1 to 6-N-glucosaminyltransferase-I (C2GlcNAcT-I) plays an important role in optimizing the binding functions of several selectin ligands, including P-selectin glycoprotein ligand. We used apolipoprotein E (ApoE)-deficient atherosclerotic mice to investigate the role of C2GlcNAcT-I in platelet and leukocyte interactions with injured arterial walls, in endothelial regeneration at injured sites, and in the formation of arterial neointima. METHODS AND

resultsArterial neointima induced by wire injury was smaller in C2GlcNAcT-I-deficient apoE(-/-) mice than in control apoE(-/-) mice (a 79% reduction in size). Compared to controls, apoE(-/-) mice deficient in C2GlcNAcT-I also demonstrated less leukocyte adhesion on activated platelets in microflow chambers (a 75% reduction), and accumulation of leukocytes at injured areas of mouse carotid arteries was eliminated. Additionally, endothelial regeneration in injured lumenal areas was substantially faster in C2GlcNAcT-I-deficient apoE(-/-) mice than in control apoE(-/-) mice. Endothelial regeneration was associated with reduced accumulation of platelet factor 4 (PF4) at injured sites. PF4 deficiency accelerated endothelial regeneration and protected mice from neointima formation after arterial injury.

conclusionsC2GlcNAcT-I deficiency suppresses injury-induced arterial neointima formation, and this effect is attributable to decreased leukocyte recruitment to injured vascular walls and increased endothelial regeneration. Both C2GlcNAcT-I and PF4 are promising targets for the treatment of arterial restenosis.

Indexed as

AnimalsApolipoproteins ECarotid Artery DiseasesCoronary RestenosisLeukocyte RollingLeukocytesMiceMice, KnockoutN-AcetylglucosaminyltransferasesPlatelet AdhesivenessTunica IntimaApolipoproteins Ebeta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferaseN-Acetylglucosaminyltransferases

Identifiers

PMID19372458
PMCPMC2735567
OpenAlexW2036689022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.